Inhaled nitric oxide in persistent pulmonary hypertension of the newborn.

PubWeight™: 3.30‹?› | Rank: Top 1%

🔗 View Article (PMID 1357245)

Published in Lancet on October 03, 1992

Authors

J D Roberts1, D M Polaner, P Lang, W M Zapol

Author Affiliations

1: Department of Anesthesia, Massachusetts General Hospital, Boston 02114.

Articles citing this

Dietary nitrate ameliorates pulmonary hypertension: cytoprotective role for endothelial nitric oxide synthase and xanthine oxidoreductase. Circulation (2012) 1.94

Nitric oxide and lung disease. Thorax (1993) 1.77

Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med (2005) 1.35

Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatr Clin North Am (2009) 1.31

Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants. Arch Dis Child Fetal Neonatal Ed (1997) 1.26

Inhaled NO as a therapeutic agent. Cardiovasc Res (2007) 1.23

Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs. J Clin Invest (1994) 1.08

Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats. J Clin Invest (1996) 1.07

Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. J Clin Invest (1994) 1.07

Conversion of inhaled nitric oxide to nitrate in man. Br J Pharmacol (1995) 1.06

Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients. Br Heart J (1995) 1.03

Nitric oxide. Ann Rheum Dis (1996) 0.99

Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects. Lancet (1993) 0.97

Regulation of Bcl-xL expression in lung vascular smooth muscle. Am J Respir Cell Mol Biol (2007) 0.96

Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2011) 0.95

Magnesium sulphate as an alternative and safe treatment for severe persistent pulmonary hypertension of the newborn. Arch Dis Child Fetal Neonatal Ed (1995) 0.94

Nitric oxide for the evaluation and treatment of pulmonary hypertension in congenital heart disease. Tex Heart Inst J (1997) 0.90

Aerosolised prostacyclin for pulmonary hypertension in neonates. Arch Dis Child Fetal Neonatal Ed (1994) 0.89

Guidelines for the safe administration of inhaled nitric oxide. Arch Dis Child Fetal Neonatal Ed (1994) 0.88

Bringing down the ROS: a new therapeutic approach for PPHN. Am J Physiol Lung Cell Mol Physiol (2008) 0.87

New perspectives for the treatment of pulmonary hypertension. Br J Pharmacol (2011) 0.87

Adenosine and adenosine receptors: Newer therapeutic perspective. Indian J Pharmacol (2009) 0.86

Utility of large-animal models of BPD: chronically ventilated preterm lambs. Am J Physiol Lung Cell Mol Physiol (2015) 0.85

Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus. Am J Physiol Lung Cell Mol Physiol (2009) 0.84

Abundance of endothelial nitric oxide synthase in newborn intrapulmonary arteries. Arch Dis Child Fetal Neonatal Ed (1995) 0.83

Extending the translational potential of targeting NO/cGMP-regulated pathways in the CVS. Br J Pharmacol (2015) 0.83

Nitric oxide administration using an oxygen hood: a pilot trial. PLoS One (2009) 0.82

NO: COPD and beyond. Thorax (1997) 0.82

Endothelial nitric oxide synthase in hypoxic newborn porcine pulmonary vessels. Arch Dis Child Fetal Neonatal Ed (1997) 0.82

Cerebral blood flow during treatment for pulmonary hypertension. Arch Dis Child Fetal Neonatal Ed (1999) 0.82

Electric Plasma-generated Nitric Oxide: Hemodynamic Effects in Patients with Pulmonary Hypertension. Am J Respir Crit Care Med (2016) 0.80

Nitric oxide and asthma. Arch Dis Child (1995) 0.80

Effect of inhaled nitric oxide on raised pulmonary vascular resistance in children with congenital heart disease. Br Heart J (1994) 0.79

Changes in oxygenation and pulmonary haemodynamics in preterm infants treated with inhaled nitric oxide. Arch Dis Child Fetal Neonatal Ed (1997) 0.79

Additional considerations for inhaled nitric oxide therapy in congenital diaphragmatic hernia. Pediatr Surg Int (1997) 0.78

Can nitric oxide-based therapy prevent bronchopulmonary dysplasia? Clin Perinatol (2012) 0.78

Inhaled nitric oxide for pulmonary hypertension after repair of exomphalos. Arch Dis Child (1993) 0.77

Simple method for monitoring concentration of inhaled nitric oxide. Lancet (1992) 0.77

Effect of inhaled nitric oxide on intrapulmonary right-to-left-shunting in two rabbit models of saline lavage induced surfactant deficiency and meconium instillation. Eur J Pediatr (1998) 0.77

Variability in uptake efficiency for pulsed versus constant concentration delivery of inhaled nitric oxide. Med Gas Res (2014) 0.77

Treatment of newborn infants with inhaled nitric oxide. Arch Dis Child Fetal Neonatal Ed (1995) 0.77

Randomised trial of three doses of inhaled nitric oxide in acute respiratory distress syndrome. Arch Dis Child (1998) 0.76

Inhaled nitric oxide applications in paediatric practice. Images Paediatr Cardiol (2002) 0.76

Nitric oxide, oxygen, and prostacyclin in children with pulmonary hypertension. Heart (1998) 0.75

Effects of magnesium sulphate and nitric oxide in pulmonary hypertension induced by hypoxia in newborn piglets. Arch Dis Child Fetal Neonatal Ed (1994) 0.75

Inhaled nitric oxide in neonates. Arch Dis Child Fetal Neonatal Ed (1997) 0.75

Persistent fetal circulation. Paediatr Child Health (2001) 0.75

Fluctuations of inspired concentrations of nitric oxide and nitrogen dioxide during mechanical ventilation. Crit Care (1999) 0.75

Nitric oxide treatment for fulminant pulmonary hypertension. Arch Dis Child (1993) 0.75

Inhaled nitric oxide in persistent pulmonary hypertension of the newborn refractory to high-frequency ventilation. Crit Care (1999) 0.75

An injection and mixing element for delivery and monitoring of inhaled nitric oxide. Biomed Eng Online (2016) 0.75

Inhaled nitric oxide treatment for preterm infants with hypoxic respiratory failure. Thorax (2000) 0.75

Health-related quality of life and its determinants in children with a congenital diaphragmatic hernia. Orphanet J Rare Dis (2013) 0.75

Alternatives to ECMO. Arch Dis Child Fetal Neonatal Ed (1994) 0.75

Successful Treatment of a Neonate with Idiopathic Persistent Pulmonary Hypertension with Inhaled Nitric Oxide via Nasal Cannula without Mechanical Ventilation. AJP Rep (2012) 0.75

Nitric oxide. Eur J Pediatr (1994) 0.75

Inhaled nitric oxide delivery and monitoring. J Clin Monit Comput (1999) 0.75

Nitric oxide inhalation increases oxygen delivery after cardiovascular surgery in adult patients whether or not they have pulmonary hypertension. J Anesth (1998) 0.75

Articles by these authors

Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med (1993) 6.22

Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA (1979) 3.69

Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med (1997) 3.13

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation (1999) 2.81

Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation (1991) 2.62

Physiologic repair of aortic atresia-hypoplastic left heart syndrome. N Engl J Med (1983) 2.50

Effects of targeted neuronal nitric oxide synthase gene disruption and nitroG-L-arginine methylester on the threshold for isoflurane anesthesia. Anesthesiology (1995) 2.13

Pulmonary hypertension in severe acute respiratory failure. N Engl J Med (1977) 2.09

Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification. J Bone Miner Res (1997) 2.09

Quantification of articular cartilage in the knee with pulsed saturation transfer subtraction and fat-suppressed MR imaging: optimization and validation. Radiology (1994) 2.05

Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients. Am J Transplant (2011) 1.93

Renal transplantation in HIV-infected patients: the Paris experience. Am J Transplant (2010) 1.92

Osteoarthritis of the knee: comparison of radiography, CT, and MR imaging to assess extent and severity. AJR Am J Roentgenol (1991) 1.91

Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys. Am J Transplant (2012) 1.90

Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol (1996) 1.90

Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J Virol (1996) 1.89

Percutaneous balloon valvotomy of congenital pulmonary stenosis using oversized balloons. J Am Coll Cardiol (1986) 1.89

Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation (2001) 1.89

The pulmonary vascular lesions of the adult respiratory distress syndrome. Am J Pathol (1983) 1.88

Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo. J Clin Invest (1997) 1.87

Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J Clin Invest (1998) 1.72

Experience with operations for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg (1981) 1.71

Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene. Circ Res (1997) 1.63

Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology (1993) 1.63

Results of the arterial switch operation for transposition of the great arteries with ventricular septal defect. Surgical considerations and midterm follow-up data. Circulation (1989) 1.60

A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma. Eur J Cancer (1995) 1.59

Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension. Crit Care Med (2001) 1.58

Selective tumor irradiation by infusional brachytherapy in nonresectable pancreatic cancer: a phase I study. Int J Radiat Oncol Biol Phys (1996) 1.55

Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor. J Med Chem (1996) 1.54

Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant (2001) 1.50

Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment. Nephrol Dial Transplant (1995) 1.49

Nonprocurement of transplantable organs in a tertiary care hospital: a focus on sociological causes. Transplantation (1996) 1.49

Correction of persistent thrombocytopenia by a boost of CD133+ selected stem cells in a patient transplanted for Wiskott-Aldrich syndrome 10 years ago. Bone Marrow Transplant (2004) 1.48

A new method for delivering radioactive cytotoxic agents in solid cancers. Int J Radiat Oncol Biol Phys (1994) 1.47

Antigens varying in affinity for the B cell receptor induce differential B lymphocyte responses. J Exp Med (1998) 1.47

Inhaled nitric oxide improves exercise capacity in patients with severe heart failure and right ventricular dysfunction. Am J Cardiol (1998) 1.47

Platelet factor 4 injection produces acute pulmonary hypertension in the awake lamb. Anesthesiology (1995) 1.46

Anomalous origin of left coronary artery from pulmonary artery. Ligation versus establishment of a two coronary artery system. J Thorac Cardiovasc Surg (1987) 1.45

Fertility preservation in girls and adolescents before chemotherapy and radiation - review of the literature. Klin Padiatr (2011) 1.45

Impact of cyclosporine reduction with MMF: a randomized trial in chronic allograft dysfunction. The 'reference' study. Am J Transplant (2006) 1.44

Immunologic events and long-term survival after combined heart and kidney transplantation: a 12-year single-center experience. J Heart Lung Transplant (2001) 1.43

Ganciclovir for severe cytomegalovirus infection in transplant recipients. Lancet (1988) 1.40

Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. Kidney Int (2006) 1.40

Transposition of the great arteries and intact ventricular septum: anatomical repair in the neonate. Ann Thorac Surg (1984) 1.37

Acute left ventricular dysfunction during unsuccessful weaning from mechanical ventilation. Anesthesiology (1988) 1.35

Long-term results after early primary repair of tetralogy of Fallot. J Thorac Cardiovasc Surg (2001) 1.35

Mitral and aortic atresia associated with hypoplastic right lung, crossover segment of right lower lobe, and anomalous scimitar-like right pulmonary venous connection with inferior vena cava: clinical, angiocardiographic, and autopsy findings in a rare case. Pediatr Dev Pathol (1999) 1.34

Bronchodilator action of inhaled nitric oxide in guinea pigs. J Clin Invest (1992) 1.34

Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology (1996) 1.33

Seal lungs collapse during free diving: evidence from arterial nitrogen tensions. Science (1985) 1.30

First-stage palliation of hypoplastic left heart syndrome. The importance of coarctation and shunt size. J Thorac Cardiovasc Surg (1986) 1.30

Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia. Leukemia (2010) 1.29

Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells. Biotechniques (1996) 1.28

Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep. Circulation (1990) 1.28

Pulmonary fibrosis in severe acute respiratory failure. Am Rev Respir Dis (1979) 1.27

Inhaled nitric oxide in congenital heart disease. Circulation (1993) 1.26

Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children. Klin Padiatr (2005) 1.26

Risk factors and long-term outcome of transplant renal artery stenosis in adult recipients after treatment by percutaneous transluminal angioplasty. Am J Transplant (2006) 1.25

Hemoglobin concentrations and blood gas tensions of free-diving Weddell seals. J Appl Physiol (1985) (1986) 1.25

Novel fast semi-automated software to segment cartilage for knee MR acquisitions. Osteoarthritis Cartilage (2006) 1.24

Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction. Science (1982) 1.23

Platelet consumption and sequestration in severe acute respiratory failure. Am Rev Respir Dis (1980) 1.22

Magnetic resonance imaging of articular cartilage. Clin Orthop Relat Res (2001) 1.22

Regional blood flow during simulated diving in the conscious Weddell seal. J Appl Physiol Respir Environ Exerc Physiol (1979) 1.21

Congenital deficiency of nitric oxide synthase 2 protects against endotoxin-induced myocardial dysfunction in mice. Circulation (2000) 1.19

Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury. Circ Res (1996) 1.19

Massive subcutaneous emphysema and sudden airway compromise after postoperative vomiting. Anesth Analg (1999) 1.19

Echocardiographic characteristics of premature infants with patient ductus arteriosus. Pediatrics (1983) 1.19

Extending the limits for modified Fontan procedures. J Thorac Cardiovasc Surg (1986) 1.19

Reduced penetrance, variable expressivity, and genetic heterogeneity of familial atrial septal defects. Circulation (1998) 1.18

Specific transplantation tolerance induced by spontaneously tolerated liver allograft in inbred strains of rats. Transplantation (1980) 1.16

Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regulated during rat pulmonary development. Pediatr Res (1998) 1.16

Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol (2000) 1.15

Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology (1991) 1.15

Pulmonary artery remodeling and pulmonary hypertension after exposure to hyperoxia for 7 days. A morphometric and hemodynamic study. Am J Pathol (1984) 1.15

Evaluation of the preterm infant for patent ductus arteriosus. Pediatrics (1983) 1.15

Feasibility, reproducibility, risks and benefits of face transplantation: a prospective study of outcomes. Am J Transplant (2011) 1.15

Transcriptional and post-transcriptional alterations of IkappaBalpha in active minimal-change nephrotic syndrome. J Am Soc Nephrol (2001) 1.14

Neutralization of low molecular weight heparin by polybrene prevents thromboxane release and severe pulmonary hypertension in awake sheep. Circulation (1990) 1.12

Neonatal repair of tetralogy of Fallot with and without pulmonary atresia. J Thorac Cardiovasc Surg (1991) 1.12

Structure and solution properties of tamarind-seed polysaccharide. Carbohydr Res (1991) 1.11

Guidelines for the pediatric perioperative anesthesia environment. American Academy of Pediatrics. Section on Anesthesiology. Pediatrics (1999) 1.11

Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. Transplantation (2001) 1.08

Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol (1994) 1.08

Reparative operations for interrupted aortic arch with ventricular septal defect. J Thorac Cardiovasc Surg (1983) 1.07

An HSV-1 vector containing the rat tyrosine hydroxylase promoter enhances both long-term and cell type-specific expression in the midbrain. J Neurochem (1997) 1.07

Early bedside detection of pulmonary vascular occlusion during acute respiratory failure. Am Rev Respir Dis (1981) 1.07

Local application of hyperosmolar glucose solution in tubal pregnancy. Lancet (1989) 1.06

Blunting of stress responses in the pulmonary circulation of infants by fentanyl. Anesth Analg (1985) 1.06

Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat. Circ Res (1995) 1.06

C5a and thromboxane generation associated with pulmonary vaso- and broncho-constriction during protamine reversal of heparin. Anesthesiology (1987) 1.06

Inhaled nitric oxide. A bronchodilator in mild asthmatics with methacholine-induced bronchospasm. Am J Respir Crit Care Med (1996) 1.04

Three-dimensional echocardiographic assessment of left ventricular wall motion abnormalities in mouse myocardial infarction. J Am Soc Echocardiogr (1999) 1.03

Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Effects on pulmonary hemodynamics and oxygenation. Anesthesiology (1994) 1.03

High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schönlein purpura. Ann Intern Med (1994) 1.02

Splenic contraction, catecholamine release, and blood volume redistribution during diving in the Weddell seal. J Appl Physiol (1985) (1996) 1.02

Pulmonary vascular remodeling in adult respiratory distress syndrome. Am Rev Respir Dis (1982) 1.01

High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study. Am J Transplant (2010) 1.01

Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d' Ile de France (GCIF). Transplantation (1999) 1.00